"The Richard A. Henson Cancer Institute Ocean Pines brings the best medical oncology, radiation, immunotherapy, nutrition, support and clinical research closer to home, offering cutting edge, high-tech care in a comfortable setting with the kindest staff."

During the past decade, TidalHealth Richard A Henson Cancer Institute conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 3 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TidalHealth Richard A Henson Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 6 trials, followed by "NRG Oncology" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TidalHealth Richard A Henson Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "TidalHealth Richard A Henson Cancer Institute" are "Invasive Breast Carcinoma" (3 trials), "Stage IIA Breast Cancer" (3 trials), "Stage IIB Breast Cancer" (3 trials), "Stage IIIA Breast Cancer" (3 trials) and "Triple-Negative Breast Carcinoma" (3 trials). Many other conditions were trialed in "TidalHealth Richard A Henson Cancer Institute" in a lesser frequency.

Most popular intervention types in "TidalHealth Richard A Henson Cancer Institute" are "Drug" (14 trials), "Other" (13 trials), "Radiation" (7 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (5 trials), "Carboplatin" (4 trials), "Paclitaxel" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "TidalHealth Richard A Henson Cancer Institute" are 15 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "TidalHealth Richard A Henson Cancer Institute". undefined are not yet recruiting, 5 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in TidalHealth Richard A Henson Cancer Institute, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in TidalHealth Richard A Henson Cancer Institute, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".